ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

KRBP Kiromic BioPharma Inc

0,60
0,00 (0,00%)
01 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Kiromic BioPharma Inc KRBP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,60 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,60 0,60
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
24.4.202414:08BWKiromic BioPharma Reports Consistent Favorable Safety,..
19.4.202422:30EDGAR2Form 8-K - Current report
10.4.202422:30EDGAR2Form RW - Registration Withdrawal Request
05.4.202422:30EDGAR2Form 8-K - Current report
02.4.202422:30EDGAR2Form 8-K - Current report
02.4.202414:18BWKiromic BioPharma Reports Favorable Safety, Tolerability,..
21.3.202422:21EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
20.3.202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.3.202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.3.202413:08BWEarly Efficacy Results Show Primary Lung Tumor Stabilization..
01.3.202414:08BWKiromic BioPharma Adds Virginia Oncology Associates, PC as..
29.2.202400:30BWKiromic BioPharma to Present at the OTC Markets’ Virtual..
28.2.202422:09GLOBEKiromic BioPharma to Present at the OTC Markets’ Virtual..
14.2.202422:30EDGAR2Form 8-K - Current report
14.2.202414:08BWResults from First Patient in Kiromic BioPharma’s..
29.1.202413:47BWKiromic BioPharma Reports Favorable Early Efficacy Results..
11.1.202422:15EDGAR2Form 8-K - Current report
05.1.202414:08BWKiromic BioPharma Reports Favorable Early Safety and..
14.12.202314:17BW Kiromic BioPharma Announces First Patient Dosed in Phase 1..
09.11.202315:49EDGAR2Form 8-K - Current report
13.9.202322:45EDGAR2Form 8-K - Current report
13.9.202322:35BWKiromic BioPharma Common Stock to Begin Trading on the OTC..
29.8.202322:15EDGAR2Form 8-K - Current report
15.8.202322:16EDGAR2Form S-8 - Securities to be offered to employees in employee..
14.8.202322:52EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10.8.202318:28EDGAR2Form 3 - Initial statement of beneficial ownership of..
27.7.202322:50EDGAR2Form 8-K - Current report
25.7.202322:28EDGAR2Form 8-K - Current report
24.7.202321:53EDGAR2Form 8-K - Current report
24.7.202321:00BWKiromic BioPharma Welcomes Two New Directors to its Board
19.7.202322:15EDGAR2Form 8-K - Current report
18.7.202322:22EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
18.7.202322:21EDGAR2Form 8-K - Current report
29.6.202322:33EDGAR2Form S-1 - General form for registration of securities under..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock